4.3. Transmission studies in commercially important fish species
At present, only a few studies have explored the experimental transmission of TSEs to teleost fish. The first attempts in this direction involved the oral and parenteral inoculation of two commercially important fish species, rainbow trout and turbot, with the 139A mouse-adapted scrapie strain [105]. Although the fish displayed no clinico-histopathological signs during the three month-experimental period, a mouse bioassay revealed that they carried residual infectivity. Specifically, mice intracranially inoculated with trout intestinal extracts one day after oral challenge were positive for brain PrPSc deposition approximately 200 days post inoculation (p.i.), despite the absence of clinical symptoms. Similar results were obtained when mice were intracerebrally (i.c.) inoculated with spleen extracts from trouts and turbots, 15 days after parenteral inoculation of the fish with scrapie material. Finally, brain tissue from parenterally inoculated turbots 15 and 90 days after challenge was also able to elicit PrPSc accumulation in the brains of recipient mice, without causing clinical disease.
Recently, we reported data on the oral transmission of BSE and scrapie to gilthead sea bream (Sparus aurata) [106]. Interestingly, at two years p.i., a number of fish that had been force-fed BSE- or scrapie-infected brain homogenates developed abnormal plaque-like deposits in their brains. Specifically, the brains of two out of five fish inoculated with scrapie developed signs of abnormal protein aggregation at 24 months p.i. These aggregates were positively stained with polyclonal antibodies raised against fish PrPs, but showed no proteinase K (PK)-resistance or Congo red birefringence (Fig. 3A). The brains of the BSE-challenged fish, however, displayed a much more striking picture, having already developed the first signs of abnormal deposition at eight months p.i. A general progression in size, PK-resistance and morphological features was observed thereafter, resulting in an impressive number of aggregates in all the brain regions examined at 24 months p.i. Three out of five fish sacrificed at this time point showed 500–800 deposits per brain section each, 70–85% of which were PK-resistant and had a mean diameter of 30 μm. These aggregates were PAS-positive, congophilic and birefringent in polarized light, indicating an amyloid or amyloid-like fibrillar structure (Fig. 3B). In contrast to the TSE-challenged individuals, no signs of abnormal aggregation or any other lesions were observed in the brains of the control fish “challenged” with bovine or ovine brain homogenates prepared from healthy animals. Altogether, the development of abnormal brain deposits in BSE-challenged sea bream constitutes an unprecedented histopathology in fish.